1. Home
  2. JG vs SKYE Comparison

JG vs SKYE Comparison

Compare JG & SKYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JG
  • SKYE
  • Stock Information
  • Founded
  • JG 2012
  • SKYE 2012
  • Country
  • JG China
  • SKYE United States
  • Employees
  • JG N/A
  • SKYE N/A
  • Industry
  • JG Computer Software: Programming Data Processing
  • SKYE Biotechnology: Pharmaceutical Preparations
  • Sector
  • JG Technology
  • SKYE Health Care
  • Exchange
  • JG Nasdaq
  • SKYE Nasdaq
  • Market Cap
  • JG 67.2M
  • SKYE 73.4M
  • IPO Year
  • JG 2018
  • SKYE N/A
  • Fundamental
  • Price
  • JG $10.89
  • SKYE $2.16
  • Analyst Decision
  • JG
  • SKYE Buy
  • Analyst Count
  • JG 0
  • SKYE 6
  • Target Price
  • JG N/A
  • SKYE $16.60
  • AVG Volume (30 Days)
  • JG 16.5K
  • SKYE 229.4K
  • Earning Date
  • JG 05-29-2025
  • SKYE 08-08-2025
  • Dividend Yield
  • JG N/A
  • SKYE N/A
  • EPS Growth
  • JG N/A
  • SKYE N/A
  • EPS
  • JG N/A
  • SKYE N/A
  • Revenue
  • JG $46,938,193.00
  • SKYE N/A
  • Revenue This Year
  • JG $10.90
  • SKYE N/A
  • Revenue Next Year
  • JG N/A
  • SKYE N/A
  • P/E Ratio
  • JG N/A
  • SKYE N/A
  • Revenue Growth
  • JG 17.73
  • SKYE N/A
  • 52 Week Low
  • JG $2.36
  • SKYE $1.14
  • 52 Week High
  • JG $20.94
  • SKYE $9.73
  • Technical
  • Relative Strength Index (RSI)
  • JG 56.52
  • SKYE 51.61
  • Support Level
  • JG $10.13
  • SKYE $2.12
  • Resistance Level
  • JG $10.75
  • SKYE $2.22
  • Average True Range (ATR)
  • JG 0.53
  • SKYE 0.19
  • MACD
  • JG -0.03
  • SKYE -0.02
  • Stochastic Oscillator
  • JG 50.00
  • SKYE 34.69

About JG Aurora Mobile Limited

Aurora Mobile Ltd provides stable, and accurate developer services for educational and medical products. It is focused on providing companies with stable and efficient push notification services. It provides a comprehensive suite of services to mobile app developers in mainland China. Through its developer services, it gains access to, aggregate, cleanse, structure and encrypt vast amounts of real-time and anonymous device-level mobile behavioral data. It offers data services such as iAPP which helps the investors to analyze opportunities in the sector, Anti-fraud helps to identify fraud risks, iAudience, iZone and other related services. The company operates and generates its revenue from the People's Republic of China.

About SKYE Skye Bioscience Inc. Common Stock

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.

Share on Social Networks: